1. Home
  2. FULC vs DDI Comparison

FULC vs DDI Comparison

Compare FULC & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$7.52

Market Cap

462.2M

Sector

Health Care

ML Signal

HOLD

Logo DoubleDown Interactive Co. Ltd. American Depository Shares

DDI

DoubleDown Interactive Co. Ltd. American Depository Shares

HOLD

Current Price

$8.55

Market Cap

433.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
DDI
Founded
2015
2008
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
462.2M
433.6M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FULC
DDI
Price
$7.52
$8.55
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$16.38
$19.00
AVG Volume (30 Days)
994.3K
43.4K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.65
Revenue Next Year
N/A
$2.64
P/E Ratio
N/A
$4.31
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$8.09
52 Week High
$15.74
$11.25

Technical Indicators

Market Signals
Indicator
FULC
DDI
Relative Strength Index (RSI) 47.30 44.96
Support Level $7.40 $8.21
Resistance Level $8.01 $9.33
Average True Range (ATR) 0.43 0.29
MACD 0.09 -0.02
Stochastic Oscillator 74.18 21.88

Price Performance

Historical Comparison
FULC
DDI

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: